Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
The Brigham And Women`S Hospital Inc. has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 6 distinct examiners and 6 distinct art units, showing complete distribution across the recorded examination assignments.
WILLIAMS, EMMALEE RAE is the busiest examiner, with 1 pending matter. No examiner concentration appears in the data, so effective management depends on coordinated docket control and separate substantive strategies for each application.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (43%) |
| §102 only | 1 (14%) |
| §112 only | 2 (29%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIAMS, EMMALEE RAE | 1 | 0.0% | +0.0% |
| JONES, CHRISTINE MICHELLE | 1 | 0.0% | +0.0% |
| SHIAO, REI TSANG | 1 | 79.9% | -33.5% |
| CHANG, KYUNG SOOK | 1 | 60.5% | +40.8% |
| MARCSISIN, ELLEN JEAN | 1 | 34.6% | +49.4% |
| MAHLUM, JONATHAN DAVIS | 1 | 50.0% | +23.3% |
| CHERNYSHEV, OLGA N | 1 | 54.5% | +34.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18477970 | LONG-TERM STABILIZATION, FORMULATION AND TABLETING OF LIVE MICROBIAL CELLS | WILLIAMS, EMMALEE RAE | — |
| 18283266 | METHODS FOR PREDICTING TREATMENT OUTCOME TO CHECKPOINT INHIBITORS IN CANCER | JONES, CHRISTINE MICHELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18012111 | Single Molecule Assays for Ultrasensitive Detection of Biomolecules | MARCSISIN, ELLEN JEAN | 8d overdue |
| 18276540 | Pectin Compositions and Methods of Use | CHANG, KYUNG SOOK | 3d overdue |
| 17698617 | METHODS OF SUPPRESSING MICROGLIAL ACTIVATION | CHERNYSHEV, OLGA N | 22d |
| 17766945 | Activators of Heme Regulated Inhibitor Kinase (HRI) | MAHLUM, JONATHAN DAVIS | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1682 | 1 |
| 1691 | 1 |
| 1613 | 1 |
| 1677 | 1 |
| 1625 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18477970 | LONG-TERM STABILIZATION, FORMULATION AND TABLETING OF LIVE MICROBIAL CELLS | WILLIAMS, EMMALEE RAE | 1653 | §103§112 | Final Rejection | — | Pending | Sep 29, 2023 |
| 18283266 | METHODS FOR PREDICTING TREATMENT OUTCOME TO CHECKPOINT INHIBITORS IN CANCER | JONES, CHRISTINE MICHELLE | 1682 | §102 | Final Rejection | — | Pending | Sep 21, 2023 |
| 18278078 | INHIBITORS OF EPHB3 SIGNALING | SHIAO, REI TSANG | 1691 | §103 | Non-Final OA | 70d | Pending | Aug 21, 2023 |
| 18276540 | Pectin Compositions and Methods of Use | CHANG, KYUNG SOOK | 1613 | §112 | Final Rejection | 3d overdue | Pending | Aug 09, 2023 |
| 18012111 | Single Molecule Assays for Ultrasensitive Detection of Biomolecules | MARCSISIN, ELLEN JEAN | 1677 | §103Other | Final Rejection | 8d overdue | Pending | Dec 21, 2022 |
| 17766945 | Activators of Heme Regulated Inhibitor Kinase (HRI) | MAHLUM, JONATHAN DAVIS | 1625 | §103 | Final Rejection | — | Pending | Apr 06, 2022 |
| 17698617 | METHODS OF SUPPRESSING MICROGLIAL ACTIVATION | CHERNYSHEV, OLGA N | 1644 | §112 | Final Rejection | 22d | Pending | Mar 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Brigham And Women`S Hospital Inc. has 7 pending office actions as of October 2026, spread across 7 art units and 7 examiners.
Emmalee Rae Williams has the most, with 1 of The Brigham And Women`S Hospital Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
